Ennogen Investments Ltd
Manufacture of basic pharmaceutical products · Dartford
ActiveUnited KingdomIncorporated 2021Private Limited Company
Financial position
Accounts to 2022-12-31 · GBP · unknown scope
Net assets
£71,447,000
Cash
—
Turnover
—
Profit / loss
−£3,000
Current assets
£50,000
Creditors < 1 year
£6,017
Equity
£71,447,000
Average employees
0
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2022-12-31GBP · unknown | 2022-01-01GBP · unknown | 2021-12-31GBP · unknown |
|---|---|---|---|
| Balance sheet | |||
| Net assets | £71,447,000 | £50,000 | £50,000 |
| Equity | £71,447,000 | £50,000 | £50,000 |
| Assets | |||
| Fixed assets | £71,403,017 | — | — |
| Current assets | £50,000 | — | £50,000 |
| Debtors | £50,000 | — | £50,000 |
| Liabilities | |||
| Creditors within one year | £6,017 | — | — |
| Net current assets | £43,983 | — | £50,000 |
| Assets less current liabilities | £71,447,000 | — | £50,000 |
| Profit & loss | |||
| Profit / loss | −£3,000 | — | £0 |
| People | |||
| Average employees | 0 | — | — |
| Source evidence | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
2 outstanding chargesAll Assets · created 2025-07-17
—
OutstandingFixed · created 2025-07-17
—
OutstandingShow 2 satisfied / released
Fixed · created 2024-04-16 · satisfied 2025-07-22
—
SatisfiedAll Assets · created 2024-04-16 · satisfied 2025-07-22
—
Satisfied